This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to
evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), to
treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to
self-quarantined and home management. The study aims to establish the safety and feasibility
of the use of FoTv vs placebo in 66 total subjects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Gordon Saxe
Collaborators:
University of California, Irvine University of California, Los Angeles